A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

Though the trial for patients with obesity and type 2 diabetes will come to an end, an obesity-only trial will continue.

Combining the diabetes medication metformin and the antihistamine clemastine increased myelin repair in people with RRMS, ...

By Stephen Beech Men with advanced prostate cancer have been offered fresh hope thanks to a "promising" new drug combination.

Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) negativity rates, compared with the control arm, in patients with relapsed ...

ASTRUM-006 is a multi-centre, double-blind, randomised Phase III clinical trial involving gastric cancer subjects.

A novel anti-obesity drug, nimacimab, has shown to significantly amplify weight loss when combined with GLP-1 therapy without additional side effects in a recent clinical trial.

The U.S. Food and Drug Administration (FDA) has granted priority review to a supplemental biologics license application for first-line treatment with Enhertu (fam-trastuzumab deruxtecan-nxki; T-DXd) ...

The main implication of our study is support for incorporating quadruplet regimens into new guidelines for the management of transplant-ineligible patients newly diagnosed multiple myeloma,” the ...

A vaccine to prevent HIV infection, the virus that leads to AIDS, has shown modest results for the first time, researchers have found, raising hopes that a disease that kills millions every year may ...